A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...

A European health committee has rejected Eli Lilly’s Alzheimer’s drug, Kisunla, because of safety concerns about possible brain swelling and bleeding. Although the drug is alr ...

After failing to pass muster with England’s drug reimbursement watchdog earlier this month, Eli Lilly’s Alzheimer’s disease ...

According to data compiled by S&P Global Market Intelligence, Viasat (NASDAQ: VSAT) stock was up by more than 17% week to date as of early Friday morning. Investors were cheered by news of the ...

The company behind the drug donanemab said it will ask regulators to reconsider the decision. View on euronews ...

Eli Lilly's Kisunla was approved in the U.S. for Alzheimer's last year, but now advisers to the European Medicines Agency say it shouldn't be approved.

Can Americans afford Trump’s tariffs? GOP’s Stefanik staying put in House RFK Jr. unveils seismic HHS layoffs, overhaul ...

President Trump has signed an executive order to end collective bargaining with federal labor unions in agencies with ...

The trend extends beyond the U.S. In February, the U.K. announced it will cut international development spending and instead ...

The nondelegation doctrine contends that Congress cannot delegate too much of its power to federal agencies. The Supreme ...

Data from those with statutory health insurance will soon be accessible for research. The BfArM is developing the necessary ...

The European Union is urging citizens across the continent to stockpile food, water and other essentials to last at least 72 ...